Awaiting development: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Area of interest

Area of interest

Type

Type

Guidance programme

Showing 311 to 311 of 311

TitleType
Zongertinib for treating HER2-mutated unresectable or metastatic non-small-cell lung cancer [ID6573]Technology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All